Henrik Krook
Fortune : 377 146 $ au 31/08/2026
Fortune : 377 146 $ au 31/08/2026
Dr. Henrik Krook is a Vice President-Commercial Operations at Egetis Therapeutics AB and an Independent Non-Executive Director at Corline Biomedical AB. He is on the Board of Directors at Corline Biomedical AB. Dr. Krook was previously employed as an Executive Vice President-Commercial by Medivir AB. He received his graduate degree from the University of Uppsala, an MBA from Stockholm School of Economics and a doctorate degree from the University of Uppsala.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/08/2026 | 460 692 ( 0,1 % ) | 377 146 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORLINE BIOMEDICAL AB | Directeur/Membre du Conseil | 01/01/2018 |
| EGETIS THERAPEUTICS AB | Directeur des opérations | 06/11/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVIR AB | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Corline Biomedical AB
Corline Biomedical AB Medical SpecialtiesHealth Technology Manufactures and markets heparin | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national